← Back to Clinical Trials
Recruiting NCT06273995

Telehealth Behavioral Activation for Teens

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Depression
Sponsor Baylor College of Medicine
Study Type INTERVENTIONAL
Phase N/A
Enrollment 250
Sex ALL
Min Age 12 Years
Max Age 18 Years
Start Date 2024-03-01
Completion 2029-03-01
Interventions
Behavioral Activation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Behavioral activation is one such empirically supported intervention. Derived from cognitive-behavioral therapy, a well-established treatment for depression, behavioral activation uses psychoeducation and skill-building to increase an individual's engagement in valued and enjoyable activities (e.g., socializing with family and friends, exercising, participating in a hobby) in order to improve depressive symptoms. Research has shown that behavioral activation is an effective intervention for depressed youth. Additionally, it has been shown as a promising intervention that can be conducted in a brief, virtual format and can be effectively implemented by both trained clinicians and trained, non-licensed interventionists. This project will provide Behavioral Activation for youth (12-17) experiencing depression or suicidal ideation who are currently enrolled in the Youth Depression Suicide Network study in Texas.

Eligibility Criteria

Inclusion Criteria: 1. Participants must be enrolled in the Texas Youth Depression Suicide Research Network (TX-YDSRN) Registry Study; 2. Be between the ages of 12- 18 or currently enrolled in high school; 3. Have a caregiver that is willing to participate in the program; 4. Be able to commit to weekly sessions for eight weeks; 5. Be currently experiencing depressive symptoms; 6. Be able to participate in telehealth services within the state of Texas; 7. Be willing to provide consent/assent (parents/legally authorized representative (LAR)/guardian or young adult participant, aged 18 or older, must be willing to provide consent; youth, aged 12-17, must be willing to provide assent); 8. Be able to read, write and speak English or Spanish sufficiently to understand the study procedures and provide written informed consent to participate in the study; 9. Be willing to dedicate appropriate time to complete scheduled study assessment and measures and attend intervention sessions (both parent

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}